Published in J Invest Dermatol on February 01, 1992
Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J Clin Invest (2003) 1.83
Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J Clin Invest (1993) 1.42
A humanized stromal bed is required for engraftment of isolated human primary squamous cell carcinoma cells in immunocompromised mice. J Invest Dermatol (2011) 1.23
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther (2010) 1.01
Mouse models with human immunity and their application in biomedical research. J Cell Mol Med (2008) 0.99
Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients. J Clin Invest (1993) 0.91
Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure. Mol Ther (2013) 0.89
In vivo targeting of integrin receptors in human skin xenografts by intravenously applied antibodies. Arch Dermatol Res (1994) 0.84
Engraftment of precursor lesions of human cutaneous neoplasms onto C.B-17 SCID mice: a useful in vivo experimental model of carcinogenesis in human skin. Arch Dermatol Res (1995) 0.78
Tuberculin-induced delayed-type hypersensitivity reaction in a model of hu-PBMC-SCID mice grafted with autologous skin. Am J Pathol (1998) 0.77
Gene therapy for a lethal genetic blistering disease: a status report. Trans Am Clin Climatol Assoc (1999) 0.75
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem (1988) 4.06
Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem (1986) 3.67
Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol (1991) 2.79
Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry (1977) 2.39
Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol (1992) 2.14
Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun (1975) 2.12
Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol (1988) 2.00
Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97
Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A (1987) 1.89
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med (1984) 1.80
Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest (1979) 1.73
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66
Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 1.65
Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol (1984) 1.61
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA (1992) 1.60
Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase. N Engl J Med (1980) 1.58
Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton. Oncogene (2001) 1.57
Interactions of basement membrane components. Biochim Biophys Acta (1983) 1.57
Congenital localized absence of the skin as a manifestation of epidermolysis bullosa. Arch Dermatol (1992) 1.51
Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry (1978) 1.47
Hailey-Hailey disease is not allelic to Darier's disease. J Invest Dermatol (1994) 1.40
Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF). J Invest Dermatol (1996) 1.39
Characterization of cellular elements in healed cultured keratinocyte autografts used to cover burn wounds. Arch Dermatol (1990) 1.39
Enzyme-linked immunosorbent assay for human skin collagenase. Coll Relat Res (1983) 1.38
A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem (1979) 1.37
Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J Biol Chem (1997) 1.37
Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol (1999) 1.34
Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol (1977) 1.33
Human skin collagenase. The role of serum alpha-globulins in the control of activity in vivo and in vitro. Proc Natl Acad Sci U S A (1971) 1.31
Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol (1998) 1.31
Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics (1994) 1.28
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum (1995) 1.28
Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest (1997) 1.27
Epidermal growth factor (EGF) promotes human keratinocyte locomotion on collagen by increasing the alpha 2 integrin subunit. Exp Cell Res (1993) 1.24
The assembly of laminin-5 subunits. J Biol Chem (1995) 1.24
Nckbeta adapter regulates actin polymerization in NIH 3T3 fibroblasts in response to platelet-derived growth factor bb. Mol Cell Biol (2000) 1.24
Human keratinocyte locomotion: the effect of selected cytokines. J Invest Dermatol (1992) 1.21
Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines. J Biol Chem (1993) 1.21
Differential proteolytic susceptibility of laminin alpha and beta subunits. Arch Biochem Biophys (1982) 1.16
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Laminin-5 inhibits human keratinocyte migration. Exp Cell Res (1997) 1.15
Isotretinoin treatment of Darier's disease. J Am Acad Dermatol (1982) 1.13
Animal and human collagenases. J Invest Dermatol (1970) 1.12
Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Arch Dermatol (1995) 1.12
Studies on purified rheumatoid synovial collagenase in vitro and in vivo. J Clin Invest (1971) 1.12
Spreading and enhanced motility of human keratinocytes on fibronectin. J Invest Dermatol (1985) 1.12
Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol Biol Cell (2000) 1.11
Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Biol Chem (1989) 1.11
NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J Invest Dermatol (1999) 1.10
The large non-collagenous domain (NC-1) of type VII collagen is amino-terminal and chimeric. Homology to cartilage matrix protein, the type III domains of fibronectin and the A domains of von Willebrand factor. Hum Mol Genet (1992) 1.09
Collagenase in human cornea: immunologic localization. Arch Ophthalmol (1980) 1.09
Cutaneous wound healing: a model for cell-matrix interactions. J Am Acad Dermatol (1985) 1.09
Aging and cross-linking of skin collagen. Biochem Biophys Res Commun (1988) 1.08
Integrin receptors and RGD sequences in human keratinocyte migration: unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J Invest Dermatol (1992) 1.08
Recessive dystrophic epidermolysis bullosa: evidence for an altered collagenase in fibroblast cultures. Proc Natl Acad Sci U S A (1977) 1.07
Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys (1996) 1.07
Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis. J Invest Dermatol (1993) 1.07
Morphea and lichen sclerosus et atrophicus. Clinical and histopathologic studies in patients with combined features. J Am Acad Dermatol (1980) 1.06
HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI. Int J Cancer (1998) 1.06
The role of human skin collagenase in epidermolysis bullosa. J Invest Dermatol (1977) 1.05
Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. J Invest Dermatol (1986) 1.05
Human nevocellular nevus cells are surrounded by basement membrane components. Immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. Lab Invest (1988) 1.04
Immunologic relationship of a purified human skin collagenase to other human and animal collagenases. Biochim Biophys Acta (1970) 1.04
Radioimmunoassay of human collagenase. Specificity of the assay and quantitative determination of in vivo and in vitro human skin collagenase. J Biol Chem (1972) 1.03
Induction of keratinocyte IL-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol (2000) 1.03
Recessive dystrophic epidermolysis bullosa. Evidence for increased collagenase as a genetic characteristic in cell culture. J Exp Med (1978) 1.03
Enhanced collagenase production by fibroblasts derived from human basal cell carcinomas. Cancer Res (1979) 1.02
Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. J Biol Chem (1994) 1.02
Inhibition of collagen degradative enzymes by retinoic acid in vitro. J Am Acad Dermatol (1982) 1.02
Characterization of procollagen synthesized by matrix-free cells isolated from chick embryo tendons. Biochemistry (1976) 1.02
Biosynthesis of collagenase by human skin fibroblasts in monolayer culture. J Biol Chem (1979) 1.00
Epidermolysis bullosa acquisita--a pemphigoid-like disease. J Am Acad Dermatol (1984) 0.99
Decreased collagenase production by regional fibroblasts cultured from skin of a patient with connective tissue nevi of the collagen type. J Invest Dermatol (1982) 0.99
The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies. J Biol Chem (2001) 0.99
Preparation of three vertebrate collagenases in pure form. Biochem Biophys Res Commun (1971) 0.99
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98
Structure and function of basement membrane. J Invest Dermatol (1982) 0.98
Epidermolysis bullosa acquisita: update and review. Clin Dermatol (2001) 0.98
Localization of the alpha 3 (V) chain of type V collagen in human skin. J Invest Dermatol (1987) 0.97
Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts. J Invest Dermatol (1992) 0.97
Gamma 2 chain of laminin-5 is recognized by monoclonal antibody GB3. J Invest Dermatol (1995) 0.97
Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma. J Biol Chem (1991) 0.97
Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol (1997) 0.97
Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts. Arch Biochem Biophys (1995) 0.96
Elevated levels of human collagenase inhibitor in blister fluids of diverse etiology. J Invest Dermatol (1986) 0.96
Interleukin-1 alpha stimulates keratinocyte migration through an epidermal growth factor/transforming growth factor-alpha-independent pathway. J Invest Dermatol (1995) 0.95
Mechanism of human keratinocyte migration on fibronectin: unique roles of RGD site and integrins. J Cell Physiol (1992) 0.95
The structure of the human skin fibroblast collagenase gene. J Biol Chem (1988) 0.95
Ultraviolet A irradiation upregulates type VII collagen expression in human dermal fibroblasts. J Invest Dermatol (1997) 0.94
Adult human keratinocytes migrating over nonviable dermal collagen produce collagenolytic enzymes that degrade type I and type IV collagen. J Invest Dermatol (1986) 0.94
Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures. J Clin Invest (1982) 0.94
Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain. Nucleic Acids Res (1994) 0.94
Focal dermal hypoplasia: abnormal growth characteristics of skin fibroblasts in culture. J Invest Dermatol (1980) 0.93
Collagen telopeptides (cross-linking sites) play a role in collagen gel lattice contraction. J Invest Dermatol (1991) 0.93
Mechanisms of human skin cell motility. Histol Histopathol (2004) 0.93